The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients

J Neurol. 1992 May;239(5):284-6. doi: 10.1007/BF00810354.

Abstract

Ten female patients suffering from catamenial epilepsy were treated with a synthetic analogue of the gonadotrophin releasing hormone (GnRH) in addition to antiepileptic drugs. Three of the patients became seizure free, in four patients seizure frequency decreased and in one patient seizures were of shorter duration. In only two of the patients was there no therapeutic effect. Adverse effects, including hot flushes, headache and increase in weight, were noticed in eight patients. These results support the hypothesis that treatment with a synthetic GnRH analogue might be helpful in patients with intractable catamenial epilepsies.

MeSH terms

  • Adult
  • Anticonvulsants / therapeutic use
  • Epilepsy / drug therapy*
  • Epilepsy / physiopathology
  • Estrogens / blood
  • Female
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Humans
  • Luteinizing Hormone / blood
  • Menstrual Cycle / physiology
  • Middle Aged
  • Triptorelin Pamoate

Substances

  • Anticonvulsants
  • Estrogens
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Luteinizing Hormone